These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8195464)

  • 21. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venlafaxine in the treatment of children and adolescents with major depression.
    Mandoki MW; Tapia MR; Tapia MA; Sumner GS; Parker JL
    Psychopharmacol Bull; 1997; 33(1):149-54. PubMed ID: 9133767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
    Pollack MH; Worthington JJ; Otto MW; Maki KM; Smoller JW; Manfro GG; Rudolph R; Rosenbaum JF
    Psychopharmacol Bull; 1996; 32(4):667-70. PubMed ID: 8993089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis.
    Entsuah AR; Rudolph RL; Chitra R
    Psychopharmacol Bull; 1995; 31(4):759-66. PubMed ID: 8851650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
    Simon JS; Aguiar LM; Kunz NR; Lei D
    J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
    Mbaya P
    Hum Psychopharmacol; 2002 Oct; 17(7):335-9. PubMed ID: 12415551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of venlafaxine in rational antidepressant therapy.
    Feighner JP
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trazodone: alternative dose regimens and sleep.
    Wheatley D
    Pharmatherapeutica; 1984; 3(9):607-12. PubMed ID: 6374681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study.
    Gerner R; Estabrook W; Steuer J; Jarvik L
    J Clin Psychiatry; 1980 Jun; 41(6):216-20. PubMed ID: 7380822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
    Rudolph RL; Fabre LF; Feighner JP; Rickels K; Entsuah R; Derivan AT
    J Clin Psychiatry; 1998 Mar; 59(3):116-22. PubMed ID: 9541154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients.
    Scharf MB; Sachais BA
    J Clin Psychiatry; 1990 Sep; 51 Suppl():13-7. PubMed ID: 2211559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of two new antidepressants.
    Gershon S; Georgotas A; Newton R; Bush D
    Adv Biochem Psychopharmacol; 1982; 32():57-68. PubMed ID: 6211943
    [No Abstract]   [Full Text] [Related]  

  • 39. Trazodone, a new antidepressant: efficacy and safety in endogenous depression.
    Kellams JJ; Klapper MH; Small JG
    J Clin Psychiatry; 1979 Sep; 40(9):390-5. PubMed ID: 383704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled study of trazodone in bulimia nervosa.
    Pope HG; Keck PE; McElroy SL; Hudson JI
    J Clin Psychopharmacol; 1989 Aug; 9(4):254-9. PubMed ID: 2671058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.